MedPath
NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

国药准字H20249167

October 22, 2024

Drug Information

注射用盐酸罗沙替丁醋酸酯

注射剂

75mg

化学药品

October 22, 2024

Company Information

Applicant Company

山西省大同经济技术开发区第一医药园区

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath